Aurobindo Pharma Ltd.
| BSE: 524804 | Sector: Health care |
| NSE: AUROPHARMA | ISIN Code: INE406A01037 |
| BSE 11:10 | 26 May | 525.80 |
2.65 (0.51%) |
OPEN
531.15 |
HIGH
531.30 |
LOW
518.30 |
| NSE 10:59 | 26 May | 522.50 |
-0.60 (-0.11%) |
OPEN
527.80 |
HIGH
531.45 |
LOW
518.05 |
| OPEN | 531.15 |
| PREVIOUS CLOSE | 523.15 |
| VOLUME | 57894 |
| 52-Week high | 1043.00 |
| 52-Week low | 514.50 |
| P/E | 20.20 |
| Mkt Cap.(Rs cr) | 30,807 |
| Buy Price | 525.30 |
| Buy Qty | 11.00 |
| Sell Price | 525.90 |
| Sell Qty | 28.00 |
Aurobindo Pharma Ltd. (AUROPHARMA) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Aurobindo Pharma | 525.80 | 2.65 | 0.51 | 3112.91 |
| Cipla | 966.45 | -4.90 | -0.50 | 2468.28 |
| Dr Reddy's Labs | 4315.40 | 10.45 | 0.24 | 2186.40 |
| Sun Pharma.Inds. | 896.20 | -14.95 | -1.64 | 2139.70 |
| Divi's Lab. | 3397.15 | -121.55 | -3.45 | 1954.72 |
| Alkem Lab | 2926.70 | -40.95 | -1.38 | 1685.08 |
| Glenmark Pharma. | 382.20 | -4.55 | -1.18 | 1649.45 |
| Zydus Lifesci. | 364.85 | -1.40 | -0.38 | 1476.20 |
| Lupin | 588.00 | -2.30 | -0.39 | 1258.62 |
| Alembic Pharma | 731.60 | -9.40 | -1.27 | 1175.39 |
| Ipca Labs. | 920.70 | -17.30 | -1.84 | 1140.77 |
| Torrent Pharma. | 2825.35 | 190.80 | 7.24 | 1137.85 |
| Gland Pharma | 2758.65 | 15.15 | 0.55 | 997.01 |
| Laurus Labs | 545.70 | -8.25 | -1.49 | 956.11 |
| Sanofi India | 6443.30 | -60.20 | -0.93 | 944.40 |
| Abbott India | 17801.90 | -266.40 | -1.47 | 690.69 |
| Ajanta Pharma | 1702.40 | 1.15 | 0.07 | 675.64 |
| Wockhardt | 255.60 | -6.80 | -2.59 | 593.29 |
| Granules India | 255.10 | 0.95 | 0.37 | 552.78 |
| Pfizer | 4236.35 | -25.85 | -0.61 | 497.61 |
Quick Links for Aurobindo Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
